Evidence map›Paper›PMID 38737192›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2024

Underdiagnosis of COPD: The Japan COPD Real-World Data Epidemiological (CORE) Study.

Yuka Koga, Sayaka Deguchi, Takeshi Matsuo, Akinori Suzuki, Gen Terashima, Takumi Tajima, Yoko Shibata, Hironori Sagara

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuka KogaPharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.ORCID 0009-0005-3462-7383
Sayaka DeguchiPharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.ORCID 0009-0003-7363-1452
Takeshi MatsuoPharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.ORCID 0009-0004-1810-8471
Akinori SuzukiPharmaceutical Division, Pharmaceutical Company, Kracie, Ltd, Tokyo, Japan.ORCID 0009-0004-2488-8363
Gen TerashimaReal World Evidence Division, JMDC Inc, Tokyo, Japan.ORCID 0000-0002-6804-5585
Takumi TajimaReal World Evidence Division, JMDC Inc, Tokyo, Japan.ORCID 0009-0007-9633-5831
Yoko ShibataDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0003-1794-0026
Hironori SagaraDepartment of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.ORCID 0000-0003-2376-1606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The prevalence of airflow obstruction in Japan is 3.8%-16.9%. This epidemiological study based on a large database aimed to reassess the prevalence of airflow obstruction in Japan and the diagnosis rate of chronic obstructive pulmonary disease (COPD). Patients and Methods: We used data regarding claims from the health insurance union and health checkups provided by JMDC. The present study included a subgroup of individuals aged ≥40 years who underwent health checkups involving spirometry between January and December 2019. The study endpoints were the prevalence of airflow obstruction, COPD diagnosis rate, disease stage, and respiratory function test results. Results: Among 102,190 participants, 4113 (4.0%) had airflow obstruction. The prevalence of airflow obstruction was 5.3% in men and 2.1% in women. Among the study population, 6.8% were current smokers, while 3.4% were never or former smokers. Additionally, the prevalence of COPD increased with age. Approximately 8.4% of participants with airflow obstruction were diagnosed with COPD. Regarding the COPD diagnosis status, participants with airflow obstruction who were diagnosed with COPD were at a more advanced stage than those not diagnosed. Finally, patients diagnosed with COPD had significantly lower FEV Conclusion: The epidemiological study based on a large database determined the COPD diagnosis rate related to airflow obstruction. The COPD diagnosis rate was extremely low among individuals who underwent health checkups, indicating the need for increased awareness about this medical condition. Moreover, primary care physicians should identify patients with suspected COPD and collaborate with pulmonologists to facilitate the early detection of COPD and enhance the COPD diagnosis rate.

Indexed as

Pulmonary Disease, Chronic ObstructiveSpirometryAdultAgedDatabases, FactualFemaleForced Expiratory VolumeHumansJapanLungMaleMiddle AgedPredictive Value of TestsPrevalenceSeverity of Illness IndexSmokingairflow obstructionCOPDepidemiologyJapanprevalencereal-world data

Identifiers

PMID38737192
PMCPMC11088415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.